Adult Cardiac

Valve Surgery in 2028: From Synthetic Valve to Transcatheter Technology

Monday, January 23, 2023

12:02 PM – 12:09 PM PT

Location: San Diego Convention Center, Ballroom 20A

Isaac George, MD

Columbia University College of Physicians and Surgeons
New York, New York, United States

Disclosure(s): , Medtronic: Advisory Board (Ongoing); Abbvie: Advisory Board (Ongoing), Consultant (Ongoing); AtriCure: Consultant (Ongoing), Speaker (Ongoing); Cardiomech: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); durvena: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Life Science: Advisory Board (Ongoing); Foldax, Inc: Advisory Board (Ongoing); Johnson and Johnson: Consultant (Ongoing); MitreMedical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); MITrx: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); neosurgery: Advisory Board (Ongoing), Consultant (Ongoing); neptune medical: Consultant (Ongoing); trisol medical: Advisory Board (Ongoing); valcare medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); VDyne: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Zimmer Biomet: Advisory Board (Ongoing), Consultant (Ongoing)

Disclosure(s):

Isaac George, MD: , Medtronic: Advisory Board (Ongoing); Abbvie: Advisory Board (Ongoing), Consultant (Ongoing); AtriCure: Consultant (Ongoing), Speaker (Ongoing); Cardiomech: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); durvena: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Life Science: Advisory Board (Ongoing); Foldax, Inc: Advisory Board (Ongoing); Johnson and Johnson: Consultant (Ongoing); MitreMedical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); MITrx: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); neosurgery: Advisory Board (Ongoing), Consultant (Ongoing); neptune medical: Consultant (Ongoing); trisol medical: Advisory Board (Ongoing); valcare medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); VDyne: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Zimmer Biomet: Advisory Board (Ongoing), Consultant (Ongoing)